These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38550363)

  • 1. Pretreatment Spatially Aware Magnetic Resonance Imaging Radiomics Can Predict Distant Brain Metastases (DBMs) After Stereotactic Radiosurgery/Radiation Therapy (SRS/SRT).
    Bae J; Mani K; Zabrocka E; Cattell R; O'Grady B; Payne D; Roberson J; Ryu S; Prasanna P
    Adv Radiat Oncol; 2024 May; 9(5):101457. PubMed ID: 38550363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
    Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
    Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery.
    Mouraviev A; Detsky J; Sahgal A; Ruschin M; Lee YK; Karam I; Heyn C; Stanisz GJ; Martel AL
    Neuro Oncol; 2020 Jun; 22(6):797-805. PubMed ID: 31956919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Peng L; Parekh V; Huang P; Lin DD; Sheikh K; Baker B; Kirschbaum T; Silvestri F; Son J; Robinson A; Huang E; Ames H; Grimm J; Chen L; Shen C; Soike M; McTyre E; Redmond K; Lim M; Lee J; Jacobs MA; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1236-1243. PubMed ID: 30353872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic modeling to predict risk of vertebral compression fracture after stereotactic body radiation therapy for spinal metastases.
    Gui C; Chen X; Sheikh K; Mathews L; Lo SL; Lee J; Khan MA; Sciubba DM; Redmond KJ
    J Neurosurg Spine; 2022 Feb; 36(2):294-302. PubMed ID: 34560656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
    Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
    J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric Magnetic Resonance Imaging in the Assessment of Primary Brain Tumors Through Radiomic Features: A Metric for Guided Radiation Treatment Planning.
    Florez E; Nichols T; E Parker E; T Lirette S; Howard CM; Fatemi A
    Cureus; 2018 Oct; 10(10):e3426. PubMed ID: 30542636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Mortality and Radiation Necrosis After Surgery With Postoperative Stereotactic Radiation in Patients With Multiple Brain Metastases.
    Bhave VM; Lamba N; Tjong MC; Aizer AA; Bi WL
    Neurosurgery; 2024 Jan; 94(1):117-128. PubMed ID: 37489905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery.
    Chen X; Parekh VS; Peng L; Chan MD; Redmond KJ; Soike M; McTyre E; Lin D; Jacobs MA; Kleinberg LR
    Neurooncol Adv; 2021; 3(1):vdab150. PubMed ID: 34901857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
    Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
    J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning.
    Jaberipour M; Soliman H; Sahgal A; Sadeghi-Naini A
    Sci Rep; 2021 Nov; 11(1):21620. PubMed ID: 34732781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate side effects of stereotactic radiotherapy and radiosurgery.
    Werner-Wasik M; Rudoler S; Preston PE; Hauck WW; Downes BM; Leeper D; Andrews D; Corn BW; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):299-304. PubMed ID: 10030253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
    Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
    Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas.
    Mitsumori M; Shrieve DC; Alexander E; Kaiser UB; Richardson GE; Black PM; Loeffler JS
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):573-80. PubMed ID: 9806517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
    Carloni G; Garibaldi C; Marvaso G; Volpe S; Zaffaroni M; Pepa M; Isaksson LJ; Colombo F; Durante S; Lo Presti G; Raimondi S; Spaggiari L; de Marinis F; Piperno G; Vigorito S; Gandini S; Cremonesi M; Positano V; Jereczek-Fossa BA
    Radiother Oncol; 2023 Jan; 178():109424. PubMed ID: 36435336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy.
    Uto M; Ogura K; Katagiri T; Takehana K; Mizowaki T
    Radiat Oncol; 2021 Jul; 16(1):140. PubMed ID: 34321033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.